vtheader-white

Program Objectives

  1. Provide a review of new information on the basic pathophysiology of ventricular arrhythmias.
  2. Provide an in-depth understanding of current management strategies used for the care of ventricular arrhythmias in various disease states, including non-pharmacological therapies such as implantable device and catheter ablation techniques.

At the conclusion of this symposium, participants should be able to:

  • Describe the science critical to the understanding and treatment of ventricular arrhythmias including:       
    • Biophysics of ablation
    • Anatomic substrate for ventricular tachycardia (VT)
  • Review the current status and future role for implantable cardioverter defibrillators (ICD) in the management of sudden cardiac death
  • Discuss the role of new techniques for VT substrate assessment including functional scar imaging, intra-procedure MRI, and high density mapping
  • Describe risk stratification and treatment including VT ablation in patients with arrhythmogenic right ventricular cardiomyopathy
  • Explain strategies to improve treatment outcome in patients with ventricular arrhythmias and structural heart disease including “bail out” strategies after failed catheter ablation
  • Review the current use/role of antiarrhythmic drug therapy for ventricular arrhythmias
  • Describe and manage complications of VT ablation
  • Identify techniques to improve ablation success for idiopathic arrhythmias including use of advanced imaging
  • Describe the status of ongoing multicenter VT-related trials and discuss which questions need to be answered by trials in the future

VT Symposium

VT Videos On Demand


register-now

shadow-div-content

Co-Hosted by:

Hospital of the University
of Pennsylvania

The Mount Sinai Hospital

Co-Sponsor:
HRS-Home logoshadow-div-content

cme

CME Certificate Fulfillment for 2016 Attendees

Click Here